Epilepsy is a common and chronic neurological disorder affecting approximately 1% of people of all ages [1,2]. Despite diagnostic and therapeutic improvements, refractory epilepsy is relatively frequent and, due to significant comorbidity, is still one of the most common serious brain disorders worldwide. Epilepsy is associated with social stigma, psychosocial adversities, and reduced quality of life for patients and their caregivers and, thus, has a substantial socioeconomic impact [3–6].
14
MAY
MAY
0